• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长非编码 RNA Lnc712 调控乳腺癌细胞增殖。

A Long Non-coding RNA Lnc712 Regulates Breast Cancer Cell Proliferation.

机构信息

Wuxi School of Medicine, Jiangnan University, Wuxi, China.

School of Food Science and Technology, Jiangnan University, Wuxi, China.

出版信息

Int J Biol Sci. 2020 Jan 1;16(1):162-171. doi: 10.7150/ijbs.36429. eCollection 2020.

DOI:10.7150/ijbs.36429
PMID:31892853
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6930380/
Abstract

Great quantity of intergenic noncoding RNAs (lncRNAs) have been identified in the mammalian genome and involved in various biological processes, especially in the development and metastasis of cancer. In this study, we identified one lncRNA, lncRNA NONHSAT028712 (Lnc712), was highly expressed in breast cancer cell lines and tissues based on microarray screening. Knockdown of Lnc712 largely inhibited breast cancer cell proliferation. Mechanistically, Lnc712 bound specifically to heat-shock protein 90 (HSP90). Interaction between Lnc712 and HSP90 is required for HSP90 binding to cell division cycle 37 (Cdc37). The Lnc712/HSP90/Cdc37 complex regulated cyclin-dependent kinase 2 (CDK2) activation and then triggered breast cancer cell proliferation. In summary, our results identified a new lncRNA regulate breast cancer proliferation though interaction with HSP90.

摘要

大量的基因间非编码 RNA(lncRNA)已在哺乳动物基因组中被鉴定出来,并参与了各种生物过程,特别是在癌症的发生和转移中。在这项研究中,我们通过微阵列筛选发现,一个 lncRNA,lncRNA NONHSAT028712(Lnc712)在乳腺癌细胞系和组织中高表达。Lnc712 的敲低极大地抑制了乳腺癌细胞的增殖。从机制上讲,Lnc712 特异性地与热休克蛋白 90(HSP90)结合。Lnc712 与 HSP90 之间的相互作用对于 HSP90 与细胞分裂周期蛋白 37(Cdc37)的结合是必需的。Lnc712/HSP90/Cdc37 复合物调节细胞周期蛋白依赖性激酶 2(CDK2)的激活,从而触发乳腺癌细胞的增殖。总之,我们的结果鉴定了一种新的 lncRNA,通过与 HSP90 的相互作用来调节乳腺癌的增殖。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/970b/6930380/90b450a618c4/ijbsv16p0162g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/970b/6930380/f1f200d2ca2b/ijbsv16p0162g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/970b/6930380/c010a072b318/ijbsv16p0162g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/970b/6930380/52ad045bd74b/ijbsv16p0162g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/970b/6930380/715bb4b986c7/ijbsv16p0162g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/970b/6930380/90b450a618c4/ijbsv16p0162g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/970b/6930380/f1f200d2ca2b/ijbsv16p0162g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/970b/6930380/c010a072b318/ijbsv16p0162g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/970b/6930380/52ad045bd74b/ijbsv16p0162g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/970b/6930380/715bb4b986c7/ijbsv16p0162g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/970b/6930380/90b450a618c4/ijbsv16p0162g005.jpg

相似文献

1
A Long Non-coding RNA Lnc712 Regulates Breast Cancer Cell Proliferation.长非编码 RNA Lnc712 调控乳腺癌细胞增殖。
Int J Biol Sci. 2020 Jan 1;16(1):162-171. doi: 10.7150/ijbs.36429. eCollection 2020.
2
Long non-coding RNA NKILA regulates expression of HSP90α, NF-κB and β-catenin proteins in the MCF-7 breast cancer cell line.长链非编码RNA NKILA调节MCF-7乳腺癌细胞系中HSP90α、NF-κB和β-连环蛋白的蛋白表达。
Mol Biol Rep. 2021 May;48(5):4563-4571. doi: 10.1007/s11033-021-06482-y. Epub 2021 Jun 14.
3
FW-04-806 inhibits proliferation and induces apoptosis in human breast cancer cells by binding to N-terminus of Hsp90 and disrupting Hsp90-Cdc37 complex formation.FW-04-806通过与热休克蛋白90(Hsp90)的N端结合并破坏Hsp90-Cdc37复合物的形成,抑制人乳腺癌细胞的增殖并诱导其凋亡。
Mol Cancer. 2014 Jun 14;13:150. doi: 10.1186/1476-4598-13-150.
4
LincK contributes to breast tumorigenesis by promoting proliferation and epithelial-to-mesenchymal transition.Linck 促进了乳腺癌的发生,促进了增殖和上皮间质转化。
J Hematol Oncol. 2019 Feb 22;12(1):19. doi: 10.1186/s13045-019-0707-8.
5
MicroRNA-361-Mediated Inhibition of HSP90 Expression and EMT in Cervical Cancer Is Counteracted by Oncogenic lncRNA NEAT1.微小 RNA-361 通过抑制 HSP90 表达和 EMT 抑制宫颈癌,而癌基因 lncRNA NEAT1 则拮抗了这一作用。
Cells. 2020 Mar 5;9(3):632. doi: 10.3390/cells9030632.
6
Long non-coding RNA BANCR indicates poor prognosis for breast cancer and promotes cell proliferation and invasion.长链非编码 RNA BANCR 表明乳腺癌预后不良,并促进细胞增殖和侵袭。
Eur Rev Med Pharmacol Sci. 2018 Mar;22(5):1358-1365. doi: 10.26355/eurrev_201803_14479.
7
Long noncoding RNA SNHG15 promotes human breast cancer proliferation, migration and invasion by sponging miR-211-3p.长链非编码RNA SNHG15通过吸附miR-211-3p促进人乳腺癌的增殖、迁移和侵袭。
Biochem Biophys Res Commun. 2018 Jan 8;495(2):1594-1600. doi: 10.1016/j.bbrc.2017.12.013. Epub 2017 Dec 5.
8
Up-regulated lncRNA AFAP1-AS1 indicates a poor prognosis and promotes carcinogenesis of breast cancer.上调的长链非编码 RNA AFAP1-AS1 预示着乳腺癌预后不良并促进其癌变。
Breast Cancer. 2019 Jan;26(1):74-83. doi: 10.1007/s12282-018-0891-3. Epub 2018 Jul 5.
9
GALNT5 uaRNA promotes gastric cancer progression through its interaction with HSP90.GALNT5 uaRNA 通过与 HSP90 的相互作用促进胃癌的进展。
Oncogene. 2018 Aug;37(33):4505-4517. doi: 10.1038/s41388-018-0266-4. Epub 2018 May 10.
10
Effects of the lncRNA NBR2 on the proliferation and autophagy of breast cancer cells under starvation conditions.饥饿条件下 lncRNA NBR2 对乳腺癌细胞增殖和自噬的影响。
Sci Rep. 2024 Sep 30;14(1):22624. doi: 10.1038/s41598-024-72181-w.

引用本文的文献

1
Non-coding RNAs, a double-edged sword in breast cancer prognosis.非编码RNA,乳腺癌预后中的一把双刃剑。
Cancer Cell Int. 2025 Apr 1;25(1):123. doi: 10.1186/s12935-025-03679-0.
2
Regulatory miRNAs, circRNAs and lncRNAs in cell cycle progression of breast cancer.调控微小 RNA、环状 RNA 和长链非编码 RNA 在乳腺癌细胞周期进展中的作用。
Funct Integr Genomics. 2023 Jul 11;23(3):233. doi: 10.1007/s10142-023-01130-z.
3
Coding roles of long non-coding RNAs in breast cancer: Emerging molecular diagnostic biomarkers and potential therapeutic targets with special reference to chemotherapy resistance.

本文引用的文献

1
Long noncoding RNA MIAT regulates apoptosis and the apoptotic response to chemotherapeutic agents in breast cancer cell lines.长链非编码 RNA MIAT 调控乳腺癌细胞系中的细胞凋亡和化疗药物的凋亡反应。
Biosci Rep. 2018 Jul 6;38(4). doi: 10.1042/BSR20180704. Print 2018 Aug 31.
2
LncRNA SNHG1 regulates the differentiation of Treg cells and affects the immune escape of breast cancer via regulating miR-448/IDO.长链非编码 RNA SNHG1 通过调节 miR-448/IDO 调控 Treg 细胞分化并影响乳腺癌的免疫逃逸。
Int J Biol Macromol. 2018 Oct 15;118(Pt A):24-30. doi: 10.1016/j.ijbiomac.2018.06.033. Epub 2018 Jun 8.
3
Triptolide, a HSP90 middle domain inhibitor, induces apoptosis in triple manner.
长链非编码RNA在乳腺癌中的编码作用:新兴的分子诊断生物标志物及潜在治疗靶点,特别涉及化疗耐药性
Front Genet. 2023 Jan 6;13:993687. doi: 10.3389/fgene.2022.993687. eCollection 2022.
4
Cell cycle related long non-coding RNAs as the critical regulators of breast cancer progression and metastasis.细胞周期相关长链非编码 RNA 作为乳腺癌进展和转移的关键调控因子。
Biol Res. 2023 Jan 3;56(1):1. doi: 10.1186/s40659-022-00411-4.
5
Long non-coding RNA MAFG-AS1 promotes proliferation and metastasis of breast cancer by modulating STC2 pathway.长链非编码RNA MAFG-AS1通过调节STC2通路促进乳腺癌的增殖和转移。
Cell Death Discov. 2022 May 5;8(1):249. doi: 10.1038/s41420-022-01043-z.
6
Long non-coding RNA BBOX1-antisense RNA 1 enhances cell proliferation and migration and suppresses apoptosis in oral squamous cell carcinoma via the miR-3940-3p/laminin subunit gamma 2 axis.长链非编码 RNA BBOX1-反义 RNA 1 通过 miR-3940-3p/层粘连蛋白亚基 γ2 轴增强口腔鳞状细胞癌中的细胞增殖、迁移和抑制凋亡。
Bioengineered. 2022 Apr;13(4):11138-11153. doi: 10.1080/21655979.2022.2059982.
7
lncRNA and breast cancer: Progress from identifying mechanisms to challenges and opportunities of clinical treatment.长链非编码RNA与乳腺癌:从机制识别到临床治疗挑战与机遇的进展
Mol Ther Nucleic Acids. 2021 Aug 19;25:613-637. doi: 10.1016/j.omtn.2021.08.005. eCollection 2021 Sep 3.
8
CDC37L1 acts as a suppressor of migration and proliferation in gastric cancer by down-regulating CDK6.CDC37L1通过下调CDK6发挥胃癌迁移和增殖抑制因子的作用。
J Cancer. 2021 Mar 31;12(11):3145-3153. doi: 10.7150/jca.56097. eCollection 2021.
9
MiR-129-5p Suppresses Cell Proliferation of Human Osteosarcoma Cancer by Down-Regulating LncRNA Lnc712.微小RNA-129-5p通过下调长链非编码RNA Lnc712抑制人骨肉瘤细胞增殖。
Cancer Manag Res. 2021 Mar 10;13:2259-2264. doi: 10.2147/CMAR.S284078. eCollection 2021.
10
LncRNA Lnc712 Promotes Tumorigenesis in Hepatocellular Carcinoma by Targeting miR-142-3p/Bach-1 Axis.长链非编码RNA Lnc712通过靶向miR-142-3p/Bach-1轴促进肝细胞癌的肿瘤发生。
Cancer Manag Res. 2020 Nov 5;12:11285-11294. doi: 10.2147/CMAR.S254950. eCollection 2020.
雷公藤内酯醇,一种热休克蛋白90中间结构域抑制剂,以三重方式诱导细胞凋亡。
Oncotarget. 2018 Apr 27;9(32):22301-22315. doi: 10.18632/oncotarget.24737.
4
High expression of long non-coding RNA MALAT1 in breast cancer is associated with poor relapse-free survival.长链非编码 RNA MALAT1 在乳腺癌中的高表达与无复发生存不良相关。
Breast Cancer Res Treat. 2018 Sep;171(2):261-271. doi: 10.1007/s10549-018-4839-2. Epub 2018 May 29.
5
GALNT5 uaRNA promotes gastric cancer progression through its interaction with HSP90.GALNT5 uaRNA 通过与 HSP90 的相互作用促进胃癌的进展。
Oncogene. 2018 Aug;37(33):4505-4517. doi: 10.1038/s41388-018-0266-4. Epub 2018 May 10.
6
Targeted cancer therapy through 17-DMAG as an Hsp90 inhibitor: Overview and current state of the art.通过 Hsp90 抑制剂 17-DMAG 进行靶向癌症治疗:概述和最新进展。
Biomed Pharmacother. 2018 Jun;102:608-617. doi: 10.1016/j.biopha.2018.03.102. Epub 2018 Apr 5.
7
The Long Non-Coding RNA XIST Interacted with MiR-124 to Modulate Bladder Cancer Growth, Invasion and Migration by Targeting Androgen Receptor (AR).长链非编码RNA XIST通过靶向雄激素受体(AR)与miR-124相互作用,调节膀胱癌的生长、侵袭和迁移。
Cell Physiol Biochem. 2017;43(1):405-418. doi: 10.1159/000480419. Epub 2017 Aug 31.
8
Structure-based virtual screening and optimization of modulators targeting Hsp90-Cdc37 interaction.基于结构的虚拟筛选及针对 Hsp90-Cdc37 相互作用的调节剂的优化。
Eur J Med Chem. 2017 Aug 18;136:63-73. doi: 10.1016/j.ejmech.2017.04.074. Epub 2017 Apr 30.
9
The HSP90 chaperone machinery.HSP90 伴侣分子机器。
Nat Rev Mol Cell Biol. 2017 Jun;18(6):345-360. doi: 10.1038/nrm.2017.20. Epub 2017 Apr 21.
10
Model driven optimization of antiangiogenics + cytotoxics combination: application to breast cancer mice treated with bevacizumab + paclitaxel doublet leads to reduced tumor growth and fewer metastasis.抗血管生成药物与细胞毒性药物联合使用的模型驱动优化:应用于接受贝伐单抗+紫杉醇双联疗法治疗的乳腺癌小鼠,可减少肿瘤生长并降低转移率。
Oncotarget. 2017 Apr 4;8(14):23087-23098. doi: 10.18632/oncotarget.15484.